From Global Recommendation to Public Health System Availability: Comparative Analysis and Access Gaps in Essential Oncology Medicines

A study presented as a poster during the II Simpósio sobre Uso Seguro de Medicamentos na Atenção Primária e Secundária. The survey shows that 12.7 per cent of treatments already included on the WHO and RENAME lists remain unavailable to the public.

Para baixar o PDF, Click aqui.